Annual report pursuant to Section 13 and 15(d)

Consolidated Statements Of Cash Flows

v3.7.0.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Operating activities:      
Net loss $ (11,175) $ (28,699) $ (8,520)
Net income (loss) from discontinued operations, net of tax 0 (10) 13,823
Net loss from continuing operations (11,175) (28,689) (22,343)
Adjustments to reconcile net loss to net cash used in continuing operating activities:      
Depreciation and amortization 3,303 3,118 2,049
Stock-based compensation 1,421 1,834 1,841
Accretion of debt discount and issuance costs 152 0 0
Loss on disposal of property and equipment 4 108 102
Change in fair value of warrant liability (137) 0 0
Deferred income taxes (229) (564) (126)
Current income tax benefit resulting from income generated from discontinued operations 0 0 (6,337)
Changes in operating assets and liabilities:      
Receivables 3,244 (1,331) (5,679)
Income taxes receivable / payable 266 (378) 1,068
Prepaid expenses and other assets (138) 748 (2,032)
Accounts payable and other accrued liabilities (1,406) 443 1,189
Accrued compensation (1,575) (2,184) 686
Deferred revenue (2,673) 2,729 5,499
Deferred rent (265) 48 (105)
Other non-current liabilities (226) 226 0
Net cash used in continuing operating activities (9,434) (23,892) (24,188)
Net cash provided by (used in) discontinued operating activities (50) 665 1,544
Net cash used in operating activities (9,484) (23,227) (22,644)
Investing activities:      
Purchases of marketable securities 0 (10,250) (33,499)
Sales and maturities of marketable securities 6,250 27,465 23,250
Purchases of property and equipment (76) (635) (1,051)
Proceeds from sale of property and equipment 0 43 0
Cash paid for acquisition of business, net of cash acquired 0 0 (11,556)
Net cash provided by (used in) continuing investing activities 6,174 16,623 (22,856)
Net cash provided by discontinued investing activities, including proceeds from sale of business 0 2,300 19,676
Net cash provided by (used in) investing activities 6,174 18,923 (3,180)
Financing activities:      
Proceeds from term loan and warrant issuance 8,000 0 0
Payments for term loan and warrant issuance costs (505) 0 0
Principal payments on capital lease obligations (513) (320) 0
Common stock repurchases to settle employee withholding liability (26) (50) (99)
Proceeds from employee stock plans 0 142 193
Net cash provided by (used in) continuing financing activities 6,956 (228) 94
Net cash used in discontinued financing activities 0 0 (59)
Net cash provided by (used in) financing activities 6,956 (228) 35
2020 922    
Effect of exchange rate changes on cash (354) (80) (252)
Net increase (decrease) in cash and cash equivalents 3,292 (4,612) (26,041)
Cash and cash equivalents, beginning of year 7,072 11,684 37,725
Cash and cash equivalents, end of year 10,364 7,072 11,684
Supplemental disclosures of net cash paid (received) during the year:      
Income taxes 22 (22) (1,145)
Interest 211 33 0
Non-cash investing and financing activities:      
Financing obligations related to prepaid expenses and other assets 182 402 0
Stock issued for acquisition of business 0 927 0
Accrued liabilities and other non-current liabilities related to leasehold improvements 0 689 0
Stock issued for acquisition of business 0 0 3,034
Proceeds from sale of business held in escrow $ 0 $ 0 $ 2,300